Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
There are countless ways to make additional income. Find the best methods that suit your skills and schedule to enhance your earnings.
17,258 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Tech ETFs can power long-term gains, especially with AI-driven growth. If you invested $1,000 years ago in VGT, you’d...
A seasoned Florida retiree nearly emptied his savings after falling for a fake FBI probe. This in-depth guide explain...
The american real estate association says Amendments 4 and 5 on Missouri's Aug. 4 ballot could raise homeownership co...
Netflix stumbled on guidance that missed expectations, triggering a price drop. But the broader picture in stock mark...
Oil remains a core part of global energy, and a patient, rules-based approach can reward investors. This article buil...
A renowned investment firm signals one cryptocurrency could jump 120% in the coming months. This guide breaks down th...
As 2025 unfolds, investors weigh the promise and pitfalls of ADMA Biologics. This guide breaks down earnings drivers,...
MercadoLibre's fourth-quarter results showed strong revenue growth, but a notable drop in profitability. This article...
Microsoft’s stock has faced a rough start this year, stirring questions about value, timing, and long-term fit. This ...
Kestra Medical (KMTS) is in focus as Q3 2026 results hit the tape. This article breaks down what the transcript revea...
When headlines warn of a strike and then show diplomacy's glow, oil markets react in real time. This guide outlines s...